MedTrace Logo

Gene Polymorphisms in Tacrolimus Drug Interactions

NCT00620841 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2008-02-22

No results posted yet for this study

Summary

A retrospective analysis of the influence of gene polymorphisms on drug interactions between calcineurin-inhibitors and concomitant drugs in renal transplant patients.

Conditions

  • Renal Transplantation

Interventions

OTHER

genotyping

Restriction fragment lenght polymorphisms

Sponsors & Collaborators

  • Fund for Scientific Research, Flanders, Belgium

    collaborator OTHER

  • KU Leuven

    lead OTHER

Principal Investigators

  • Dirk R Kuypers, MD, PhD · Universitaire Ziekenhuizen KU Leuven

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2008-01-31
Completion
2008-01-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00620841 on ClinicalTrials.gov